
Around one in four women who struggle with infertility have difficulty carrying a pregnancy to term

Users will be able to access results, prescriptions and educational content from home via an app

Asieris Pharmaceuticals aims to use both in-house discoveries and external partnerships to expand its gynaecological portfolio

Nitya Dintakurti made it her mission to develop tools to help women navigate and better understand menopause

Labs-based companies will receive direct mentorship as well as connections to other companies

The test is aimed at diagnosing patients clinically suspected of endometriosis

While there have been advances in fertility care, doctors have said that equity remains a challenge across countries, cultures and economies

Researchers found inconsistencies when comparing UK clinics, Integrated Care Boards and international guidelines

Natural Cycles is currently the only app that has been cleared by the FDA to be used and marketed as birth control

By Isabella Fricker, women’s health advocate

A new software promises to detect breast cancer in women with dense breasts

This week we meet Talia Soen, founder and CEO of Happy Things

The method has been shown to be able to detect particles of genetic material that are left behind in the liquid media young embryos are grown...

Cryo-Logix aims to utilise clinic EMR data to ensure streamlined communication between systems

Femtech World Jobs is your go-to source for femtech recruitment opportunities We’ve rounded up our picks of posts from the past week. Head over to femtechworldjobs.com...

Diversity, equity, and inclusion (DEI) are essential elements of a thriving workplace, but how do we ensure these policies are not built on empty promises? This...

Health in Her HUE promotes a personalised and equitable approach to healthcare

Uterine fibroids remain a vastly underserved global health issue, affecting up to 80 per cent of women by the age of 50

A digital stethoscope has been shown to identify twice as many cases of peripartum cardiomyopathy as compared to regular care

The move is hoped to be an opportunity for testing important biomarkers for the more than 80 million people who menstruate in the US